MULTIPLE STEPS IN CARCINOGENESIS INVOLVING ALTERATIONS OF MULTIPLE TUMOR-SUPPRESSOR GENES

被引:118
作者
YOKOTA, J
SUGIMURA, T
机构
[1] Biology Division, Natl. Cancer Center Research Inst., Chuo-ku, Tokyo 104, 1-1
关键词
TUMOR SUPPRESSOR GENE; MULTISTAGE CARCINOGENESIS; RB; P53; LOSS OF HETEROZYGOSITY;
D O I
10.1096/fasebj.7.10.8344488
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent advances in molecular genetics have made it possible to understand the molecular mechanisms of human cancer progression. The results indicate that clinically evident tumor cells already carry multiple genetic alterations and further accumulation of genetic alteration occurs during tumor progression. It is widely accepted that tumor suppressor genes play a central role in the genesis and progression of human cancers, as frequent alterations of tumor suppressor genes have been found in a variety of human cancers. Molecular analyses of various stages of human cancers, from precancerous lesions to advanced or metastatic tumors, indicate that sequential accumulation of genetic alterations correlates with more malignant phenotypes of tumor cells. Furthermore, biological studies of tumor suppressor genes have revealed that a single gene defect is not sufficient for the cells to gain growth advantage and start clonal expansion in vivo. These results are consistent with the concept of human multistage carcinogenesis, indicated by experimental animal models and epidemiological studies. Although it is supposed that there are more than 20 tumor suppressor genes in the human genome, only a few tumor suppressor genes have been identified to date. Thus, further studies should focus on the identification and characterization of novel tumor suppressor genes, and molecular analysis of those genes in human cancer would be of great help in clarifying the multiple steps in the process of human carcinogenesis.
引用
收藏
页码:920 / 925
页数:6
相关论文
共 56 条
[1]  
BAKER SJ, 1990, CANCER RES, V50, P7717
[2]   MUTATION SELECTION AND NATURAL-HISTORY OF CANCER [J].
CAIRNS, J .
NATURE, 1975, 255 (5505) :197-200
[3]   ALTERED EXPRESSION OF THE RETINOBLASTOMA GENE-PRODUCT IN HUMAN SARCOMAS [J].
CANCE, WG ;
BRENNAN, MF ;
DUDAS, ME ;
HUANG, CM ;
CORDONCARDO, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) :1457-1462
[4]   EXPRESSION OF RECESSIVE ALLELES BY CHROMOSOMAL MECHANISMS IN RETINOBLASTOMA [J].
CAVENEE, WK ;
DRYJA, TP ;
PHILLIPS, RA ;
BENEDICT, WF ;
GODBOUT, R ;
GALLIE, BL ;
MURPHREE, AL ;
STRONG, LC ;
WHITE, RL .
NATURE, 1983, 305 (5937) :779-784
[5]   GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE [J].
CHEN, PL ;
CHEN, YM ;
BOOKSTEIN, R ;
LEE, WH .
SCIENCE, 1990, 250 (4987) :1576-1580
[6]   DIFFERENCES IN PATTERNS OF ALLELIC LOSS BETWEEN 2 COMMON TYPES OF ADULT CANCER, BREAST AND COLON-CARCINOMA, AND WILMS-TUMOR OF CHILDHOOD [J].
DEVILEE, P ;
VANDENBROEK, M ;
MANNENS, M ;
SLATER, R ;
CORNELISSE, CJ ;
WESTERVELD, A ;
KHAN, PM .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (06) :817-821
[7]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[8]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[9]  
FEARON ER, 1992, PRINCESS TAKAMATSU S, V22, P37
[10]   CLONAL ALLELE LOSS IN GASTROINTESTINAL CANCERS [J].
FEY, MF ;
HESKETH, C ;
WAINSCOAT, JS ;
GENDLER, S ;
THEIN, SL .
BRITISH JOURNAL OF CANCER, 1989, 59 (05) :750-754